Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

AI has the potential to transform life sciences commercialization, but only if we design it around people. Machines bring ...

ResMed's first-quarter result broadly met market expectations, though rising margins and potential for further capital ...

Chatbots weren't designed for mental health, but they are increasingly used for therapy. What are the risks an benefits?

Playground manufacturers, parents and educators shed light on how playgrounds here balance risk and safety. Read more at ...

Markets have turned upbeat amid optimism that the 39-day US shutdown could soon come to an end, after a weekend of dealmaking in Washington. A new bill quickly advanced in a key S ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

Researchers tested an LLM-powered robot's ability to fetch butter. The result? Today’s models still struggle at basic ...

Accuray's weak quarter signals ongoing challenges despite new CEO plans. Discover key insights and risks before investing in ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Women are finding that when it comes to dating, advice, and listening, AI understands what they need more than the people in ...

Ten stocks soared higher on Wednesday, mirroring a broader market rally, as investors continued to take path from a flurry of ...